To take this further, the researchers are now searching for molecules that can reduce the levels of miRNA-155, which will hopefully restore normal levels of SNX27. If successful, this may eventually lead to new treatment avenues to help reduce brain cell loss in individuals with both Alzheimer’s and Down’s syndrome.